Clinical Trial

Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Name: Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma — clinical trial record (NCT07595770)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ANCRE

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to systematically evaluate the safety and efficacy of adalimumab combined with paclitaxel, carboplatin, and short-course radiotherapy in the neoadjuvant treatment of esophageal squamous cell carcinoma.

Trial Details

NCT Number	NCT07595770
Lead Sponsor	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Collaborators: Jiangsu HengRui Medicine Co., Ltd.
Conditions	Esophageal Squamous Cell Carcinoma (ESCC)
Enrollment	37 participants
Start Date	2026-05-22
Primary Completion	2028-01-01 (estimated)
Study Completion	2029-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-19